Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years

Rebecca Lodwick, Dominique Costagliola, Peter Reiss, Carlo Torti, Ramón Teira, Maria Dorrucci, Bruno Ledergerber, Amanda Mocroft, Daniel Podzamczer, Alessandro Cozzi-Lepri, Niels Obel, Bernard Masquelier, Schlomo Staszewski, Federico García, Stephane De Wit, Antonella Castagna, Andrea Antinori, Ali Judd, Jade Ghosn, Giota TouloumiCristina Mussini, Xavier Duval, José Ramos, Laurence Meyer, Josiane Warsawski, Claire Thorne, Joan Masip, Santiago Pérez-Hoyos, Deenan Pillay, Ard van Sighem, Sergio Lo Caputo, Huldrych Günthard, Roger Paredes, Andrea De Luca, Dimitrios Paraskevis, Céline Fabre-Colin, Jesper Kjaer, Genèvieve Chêne, Jens D Lundgren, Andrew N Phillips, Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE)

43 Citationer (Scopus)

Abstract

Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to approach that of the general population in some successfully treated subgroups. However, to attain these life expectancies, viral suppression must be maintained for decades.
OriginalsprogEngelsk
TidsskriftArchives of Internal Medicine
Vol/bind170
Udgave nummer5
Sider (fra-til)410-9
Antal sider10
DOI
StatusUdgivet - 8 mar. 2010

Fingeraftryk

Dyk ned i forskningsemnerne om 'Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years'. Sammen danner de et unikt fingeraftryk.

Citationsformater